11 August 2021: Clinical Research
Using the Diaphragm as a Tracking Surrogate in CyberKnife Synchrony Treatment
Guo-quan Li 1A , Jing Yang 1A , Yan Wang 2C , Mengjun Qiu 3B , Zeyu Ding 1D , Sheng Zhang 1E , Sheng-li Yang 1G* , Zhenjun Peng 1F*DOI: 10.12659/MSM.930139
Med Sci Monit 2021; 27:e930139
Table 1 Patient characteristics (N=24).
| Characteristics* | |
|---|---|
| Age, years | 56 (35–69) |
| Disease, n (%) | |
| Lung cancer | 14 (58.3) |
| Liver cancer | 6 (25) |
| Colorectal cancer | 4 (16.7) |
| Tumor lobe location, n (%) | |
| Right middle lobe | 3 (12.5) |
| Right lower lobe | 12 (50) |
| Left lower lobe | 9 (37.5) |
| Gross tumor volume, cm | 17.54 (7.09–36.3) |
| Planning target volume, cm | 34.27 (13.04–95.25) |
| Distance between gross tumor volume and diaphragm, mm | 65.28 (27.94–141.53) |
| Total dose, Gy | 45 (35–60) |
| Fraction | 5 (3–8) |
| Treatment time (min) per fraction | 38 (31–54) |
| * Values are median (range) unless noted otherwise. | |